Simple Drape Bundle Could Cut 38% of Maternal PPH Deaths: Lancet Series

For hospital administrators and health IT leaders, the E-MOTIVE strategy presents a rare convergence of simplicity and evidence. A calibrated drape costing pennies can now objectively trigger a bundled response to postpartum hemorrhage, replacing dangerous guesswork with data. With PPH contributing as high as 38% of India’s maternal deaths, integrating this into delivery room protocols—and potentially into digital health dashboards for compliance tracking—could be the most cost-effective investment a health system makes this decade.

On June 12, 2026, The Lancet published a groundbreaking three-part series on postpartum hemorrhage (PPH), bringing renewed global attention to a deceptively simple, low-cost intervention—the E-MOTIVE bundle—that could dramatically reduce maternal deaths. Led by Professor Arri Coomarasamy of the University of Oxford, with key contributions from the WHO’s HRP, the series solidifies evidence from the 2023 E-MOTIVE cluster-randomized trial involving over 80 hospitals in low- and middle-income countries. That trial demonstrated that replacing subjective blood-loss estimation with a calibrated drape and immediately applying a bundle of treatments (uterine massage, oxytocin, tranexamic acid, intravenous fluids) slashes rates of severe bleeding and mortality. The Lancet series builds on this by providing implementation frameworks, cost-effectiveness data, and global burden analyses, positioned to reshape obstetric care protocols worldwide.

“

PPH accounts for 19.9% to 38% of maternal deaths across the country, with figures exceeding 50% in high-burden regions such as the Northeast and parts of Delhi.

For India, the urgency cannot be overstated. PPH accounts for 19.9% to 38% of maternal deaths across the country, with figures exceeding 50% in high-burden regions such as the Northeast and parts of Delhi. Despite significant progress—India’s maternal mortality ratio (MMR) fell to approximately 97 per 100,000 live births in the 2018–2020 period—thousands of women still die from PPH each year, especially those with anemia, those delivering at home, or those in under-resourced facilities. The incidence of PPH is 2–4% for vaginal deliveries and around 6% for cesareans, making it a pervasive yet largely preventable crisis. The E-MOTIVE strategy meets India’s needs head-on: the simple plastic drape costs pennies, requires minimal training, and can be deployed by midwives and nurses, fitting seamlessly into the country’s vast public health network of over 150,000 sub-centers and 25,000 primary health centers.

The clinical paradigm shift is profound. Conventional care often relies on visual estimation of blood loss, which is notoriously inaccurate; providers frequently underestimate bleeding, delaying life-saving treatment. The E-MOTIVE drape, with its clear measurement markings, triggers an objective alert when blood loss crosses a threshold, activating the bundled protocol without hesitation. This moves PPH management from a reactive, fragmented sequence to a proactive, standardized system. Evidence shows such bundled approaches prevent the cascade from mild hemorrhage to hypovolemic shock, disseminated intravascular coagulation, and death. Moreover, the bundle integrates essential medicines that are already on WHO’s Essential Medicines List, reinforcing procurement channels rather than requiring novel drugs.